Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Venegas Alen supplement health benefit claims prohibited by FTC in proposed settlement.

This article was originally published in The Tan Sheet

Executive Summary

VENEGAS ALEN SUPPLEMENT HEALTH CLAIMS PROHIBITED BY FTC until the company obtains competent and reliable substantiation for its dietary supplement product, the Federal Trade Commission said in a proposed settlement agreement released Oct. 29. Brooklyn, N.Y.-based Venegas was making a number of "unsubstantiated" health claims for Alen, a powdered nutritional supplement containing wheat germ, wheat bran, soybean extract and seaweed extract, primarily in New York City in such publications as El Diario, a Spanish-language newspaper, and on a local Spanish television station, according to FTC.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087735

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel